Literature DB >> 15289845

Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladder.

Stefan Krüger1, Frank Noack, Andreas Böhle, Alfred C Feller.   

Abstract

Tumor stage and lymph node status are currently the most established prognostic factors in muscle-invasive bladder cancer. However, there is still a need for new parameters allowing to assess the prognosis more accurately. A recently introduced morphologic classification of tumor growth, which distinguishes three growth patterns (nodular, trabecular, and infiltrative type), was retrospectively applied to a collective of 153 muscle-invasive bladder carcinomas in order to examine its prognostic relevance. Nodular pattern was found in 34 cases (22%), trabecular pattern in 97 cases (63%) and infiltrative pattern in 22 cases (14%) as the dominant type of tumor growth. The majority of cases (54%) displayed more than one tumor growth pattern. A two-tiered classification considering the worst type of tumor growth (non-infiltrative or infiltrative type) yielded 74 non-infiltrative tumors (55%) and 69 infiltrative tumors (45%). The former group was associated with a significantly better disease-related survival than the latter (p=0.007 by univariate Cox regression analysis). Moreover, the two-tiered classification was identified, besides tumor stage (p=0.036) and lymph node status (p=0.0001), as an independent predictor of disease-related survival in a multivariate analysis (p=0.029). In conclusion, our data suggest that the morphologic pattern of tumor growth is significantly associated with the clinical course of advanced transitional cell carcinomas of the bladder. The tumor growth classification proposed here may serve as an additional tool to predict the prognosis of patients undergoing radical cystectomy for bladder cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15289845

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

1.  Prognostic implication of infiltrative growth pattern and establishment of novel risk stratification model for survival in patients with upper urinary tract urothelial carcinoma.

Authors:  Takeshi Hashimoto; Jun Nakashima; Rie Inoue; Tatsuo Gondo; Yoshio Ohno; Masaaki Tachibana
Journal:  Int J Clin Oncol       Date:  2013-04-03       Impact factor: 3.402

2.  [Non-muscle-invasive high-grade bladder cancer].

Authors:  G Gakis; A Stenzl; T Horn; J E Gschwend; W Otto; M Burger
Journal:  Urologe A       Date:  2015-04       Impact factor: 0.639

3.  Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract.

Authors:  C Langner; G Hutterer; T Chromecki; P Rehak; R Zigeuner
Journal:  Virchows Arch       Date:  2006-03-09       Impact factor: 4.064

4.  Prognostic significance of tumor budding in muscle invasive urothelial carcinomas of the bladder.

Authors:  Ülkü Küçük; Sümeyye Ekmekçi; Ebru Çakır; Zübeyde Ekin; Batuhan Ergani; Gökhan Rahmi Ekin
Journal:  Turk J Urol       Date:  2018-08-31

5.  New invasive patterns as a prognostic factor for superficial esophageal cancer.

Authors:  Eisuke Ito; Soji Ozawa; Hiroshi Kijima; Akihito Kazuno; Takayuki Nishi; Osamu Chino; Hideo Shimada; Makiko Tanaka; Shigeaki Inoue; Sadaki Inokuchi; Hiroyasu Makuuchi
Journal:  J Gastroenterol       Date:  2012-05-12       Impact factor: 7.527

6.  Clinical significance of subepithelial growth patterns in non-muscle invasive bladder cancer.

Authors:  Makito Miyake; Shuya Hirao; Hisakazu Mibu; Masahiro Tanaka; Kenji Takashima; Keiji Shimada; Kazuya Hirao
Journal:  BMC Urol       Date:  2011-08-05       Impact factor: 2.264

7.  Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder.

Authors:  Makito Miyake; Shunta Hori; Yosuke Morizawa; Yoshihiro Tatsumi; Michihiro Toritsuka; Sayuri Ohnishi; Keiji Shimada; Hideki Furuya; Vedbar S Khadka; Youping Deng; Kenta Ohnishi; Kota Iida; Daisuke Gotoh; Yasushi Nakai; Takeshi Inoue; Satoshi Anai; Kazumasa Torimoto; Katsuya Aoki; Nobumichi Tanaka; Noboru Konishi; Kiyohide Fujimoto
Journal:  Oncotarget       Date:  2017-05-30

8.  Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial.

Authors:  Amanda Eustace; Joely J Irlam; Janet Taylor; Helen Denley; Shailesh Agrawal; Ananya Choudhury; David Ryder; Jonathan J Ord; Adrian L Harris; Ana M Rojas; Peter J Hoskin; Catharine M L West
Journal:  Radiother Oncol       Date:  2013-06-14       Impact factor: 6.280

9.  Expression of OCT4A: the first step to the next stage of urothelial bladder cancer progression.

Authors:  Wojciech Jóźwicki; Anna A Brożyna; Jerzy Siekiera
Journal:  Int J Mol Sci       Date:  2014-09-11       Impact factor: 5.923

10.  Disabled Homolog 2 (DAB2) Protein in Tumor Microenvironment Correlates with Aggressive Phenotype in Human Urothelial Carcinoma of the Bladder.

Authors:  Yoshitaka Itami; Makito Miyake; Sayuri Ohnishi; Yoshihiro Tatsumi; Daisuke Gotoh; Shunta Hori; Yosuke Morizawa; Kota Iida; Kenta Ohnishi; Yasushi Nakai; Takeshi Inoue; Satoshi Anai; Nobumichi Tanaka; Tomomi Fujii; Keiji Shimada; Hideki Furuya; Vedbar S Khadka; Youping Deng; Kiyohide Fujimoto
Journal:  Diagnostics (Basel)       Date:  2020-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.